Your browser doesn't support javascript.
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study.
Dziedzic, Arkadiusz; Issa, Julien; Hussain, Salman; Tanasiewicz, Marta; Wojtyczka, Robert; Kubina, Robert; Konwinska, Marta Dyszkiewicz; Riad, Abanoub.
  • Dziedzic A; Department of Conservative Dentistry with Endodontics, Medical University of Silesia, Katowice, Poland.
  • Issa J; Department of Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.
  • Hussain S; Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
  • Tanasiewicz M; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Masaryk University, Brno, Czechia.
  • Wojtyczka R; Department of Conservative Dentistry with Endodontics, Medical University of Silesia, Katowice, Poland.
  • Kubina R; Department of Microbiology and Virology, Medical University of Silesia, Sosnowiec, Poland.
  • Konwinska MD; Department of Pathology, Medical University of Silesia, Sosnowiec, Poland.
  • Riad A; Department of Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.
Front Public Health ; 10: 938067, 2022.
Article in English | MEDLINE | ID: covidwho-1993901
ABSTRACT
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Front Public Health Year: 2022 Document Type: Article Affiliation country: Fpubh.2022.938067

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Female / Humans / Male Country/Region as subject: Europa Language: English Journal: Front Public Health Year: 2022 Document Type: Article Affiliation country: Fpubh.2022.938067